Viewing StudyNCT04508530

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 3:03 PM
Last Modification Date: 2024-10-26 @ 1:42 PM
Study NCT ID: NCT04508530
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-07-09
First Post: 2020-08-07
Brief Title: Phase III Study To Compare The Effect of Panzyga Versus Placebo in Patients With Pediatric Acute-onset Neuropsychiatric Syndrome PANSPANDAS
Sponsor: Octapharma
Organization: Octapharma
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Pediatric Acute-Onset Neuropsychiatric Syndrome
Keywords: